The secretion of TG2 from cells to the ECM has been implicated in outside-in signalling in several cancer models [16, 22, 34], and recently TG2 has been proposed to be externalised via microvesicles/extracellular vesicles (EVs) in cancer [35–37] and other systems [38–40]. Here, TGM2 is linked to cancer.